| 000 | 01847 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250514195457.0 | ||
| 264 | 0 | _c20040927 | |
| 008 | 200409s 0 0 eng d | ||
| 022 | _a0008-6363 | ||
| 024 | 7 |
_a10.1016/j.cardiores.2004.05.018 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJasmin, Jean-François | |
| 245 | 0 | 0 |
_aLung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. _h[electronic resource] |
| 260 |
_bCardiovascular research _cSep 2004 |
||
| 300 |
_a747-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCaveolin 1 |
| 650 | 0 | 4 | _aCaveolin 2 |
| 650 | 0 | 4 | _aCaveolin 3 |
| 650 | 0 | 4 |
_aCaveolins _xanalysis |
| 650 | 0 | 4 |
_aCyclin D1 _xanalysis |
| 650 | 0 | 4 | _aCyclin D3 |
| 650 | 0 | 4 |
_aCyclins _xanalysis |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xanalysis |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xetiology |
| 650 | 0 | 4 |
_aImmunoblotting _xmethods |
| 650 | 0 | 4 |
_aImmunohistochemistry _xmethods |
| 650 | 0 | 4 |
_aLung _xchemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSTAT3 Transcription Factor |
| 650 | 0 | 4 |
_aSignal Transduction _xphysiology |
| 650 | 0 | 4 |
_aTrans-Activators _xanalysis |
| 700 | 1 | _aMercier, Isabelle | |
| 700 | 1 | _aHnasko, Robert | |
| 700 | 1 | _aCheung, Michelle W-C | |
| 700 | 1 | _aTanowitz, Herbert B | |
| 700 | 1 | _aDupuis, Jocelyn | |
| 700 | 1 | _aLisanti, Michael P | |
| 773 | 0 |
_tCardiovascular research _gvol. 63 _gno. 4 _gp. 747-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cardiores.2004.05.018 _zAvailable from publisher's website |
| 999 |
_c15005589 _d15005589 |
||